Trial of Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation After Repair of Atrioventricular Septal Defect--Pediatric Heart Network - No Study Results Posted

Trial of Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation After Repair of Atrioventricular Septal Defect--Pediatric Heart Network (AceiMR)

This study has been terminated.

( lower than expected enrollment )

Study NCT00113698 Information provided by National Heart, Lung, and Blood Institute (NHLBI)

First Received: June 9, 2005 Last Updated: February 11, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been terminated.
Study Completion Date:	January 2006
Primary Completion Date:	November 2005 (Final data collection date for primary outcome measure)

No publications provided by National Heart, Lung, and Blood Institute (NHLBI)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Li JS, Colan SD, Sleeper LA, Newburger JW, Pemberton VL, Atz AM, Cohen MS, Golding F, Klein GL, Lacro RV, Radojewski E, Richmond ME, Minich LL. Lessons learned from a pediatric clinical trial: the Pediatric Heart Network angiotensin-converting enzyme inhibition in mitral regurgitation study. Am Heart J. 2011 Feb;161(2):233-40.

Atz AM, Hawkins JA, Lu M, Cohen MS, Colan SD, Jaggers J, Lacro RV, McCrindle BW, Margossian R, Mosca RS, Sleeper LA, Minich LL; Pediatric Heart Network Investigators. Surgical management of complete atrioventricular septal defect: associations with surgical technique, age, and trisomy 21. J Thorac Cardiovasc Surg. 2011 Jun;141(6):1371-9. Epub 2010 Dec 15.